A Phase I, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, 4-Period Cross-Over Study Assessing the Duration of Effect of Lasmiditan on Simulated Driving Performance in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Lasmiditan (Primary) ; Diphenhydramine
- Indications Migraine
- Focus Pharmacodynamics
- Sponsors Eli Lilly
- 12 Jul 2018 Status changed from recruiting to completed.
- 22 Jun 2018 Planned End Date changed from 1 Jul 2018 to 1 Jun 2018.
- 22 Jun 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jun 2018.